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Summary 
P r e s e n c e o f a t r i a l n a t r i u r e t i c f a c t o r ( A N F ) - l i k e mate­
r i a l was d e m o n s t r a t e d by r a d i o i m m u n o a s s a y i n a s c i t i c 
f l u i d o f 14 p a t i e n t s w i t h c i r r h o s i s o f t h e l i v e r . Im-
m u n o r e a c t i v e ANF c o n c e n t r a t i o n s (M+SEM) were 2.4 + 0.5 
f m o l / m l i n a s c i t e s , s i g n i f i c a n t l y l o w e r (p < 0.001) 
t h a n t h e c o r r e s p o n d i n g plasma c o n c e n t r a t i o n s o f 15.5 + 
2.6 f m o l / m l . High p e r f o r m a n c e g e l p e r m e a t i o n c h r o m a t o ­
g r a p h y and r e v e r s e phase h i g h p e r f o r m a n c e c h r o m a t o ­
g r a p h y o f t h e a s c i t i c ANF i m m u n o r e a c t i v i t y showed c o r ­
r e s p o n d e n c e t o t h e a l p h a human ANF( 99-1 26 ) . ANF l e v e l s 
i n a s c i t e s were s i g n i f i c a n t l y (ρ < 0.01) c o r r e l a t e d t o 
l e v e l s i n plasma ( r = 0 . 6 6 ) . 
I n p a t i e n t s w i t h c i r r h o s i s o f t h e l i v e r and a s c i t e s t h e p a t h o ­
p h y s i o l o g i c a l r o l e o f ANF has n o t been f u l l y e l u c i d a t e d ( 1 , 2 ) . 
F o l l o w i n g i n t r a v e n o u s r e i n f u s i o n o f a s c i t e s e l e v a t e d ANF plasma 
l e v e l s have been r e p o r t e d ( 3 , 4 , 5 ) . T h i s m i g h t be due t o ANF r e ­
l e a s e s t i m u l a t e d by t h e hemodynamic changes f o l l o w i n g a s c i t e s 
i n f u s i o n or due t o e l e v a t e d ANF c o n c e n t r a t i o n s i n a s c i t i c f l u i d . 
Whereas t h e p r e s e n c e o f a t r i a l n a t r i u r e t i c f a c t o r (ANF) has been 
d e m o n s t r a t e d i n v a r i o u s f l u i d s o f t h e human body, such as plasma 
( 6 ) , u r i n e ( 7 ) and c e r e b r o s p i n a l f l u i d ( 8 ) , a s c i t i c f l u i d has n o t 
been examined as y e t f o r t h e o c c u r e n c e o f ANF. I n t h i s s t u d y t h e 
p r e s e n c e o f ANF i n a s c i t i c f l u i d was i n v e s t i g a t e d . 
S u b j e c t s and Methods 
F o u r t e e n p a t i e n t s (11 men, 3 women, aged 42 t o 81 y e a r s ) w i t h 
b i o p s y p r o v e n c i r r h o s i s o f t h e l i v e r and a s c i t e s were i n v e s t i ­
g a t e d . 
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D e t e r m i n a t i o n o f ANF by r a d i o i m m u n o a s s a y . S i m u l t a n e o u s l y o b t a i n e d 
samp 1 es 5T a s c i t i c f l u i d and p e r i p h e r a 1 venous b l o o d were drawn 
i n t o p r e - c o o l e d s y r i n g e s and i m m e d i a t e l y t r a n s f e r r e d t o p r e - c o o l e d 
p o l y s t y r e n e t u b e s c o n t a i n i n g 500 k a l l i k r e i n i n h i b i t o r u n i t s 
a p r o t i n i n per ml and 1 mg sodium EDTA p e r m l . Samples were 
c e n t r i f u g e d a t 4° C, t h e s u p e r n a t a n t was i m m e d i a t e l y f r o z e n and 
s t o r e d a t - 80° C. E x t r a c t i o n o f a s c i t e s a l i q u o t s as w e l l as RIA 
p r o c e d u r e s were p e r f o r m e d i n t h e same way as f o r plasma samples; 
p r o c e d u r e s were m o d i f i e d f r o m ( 6 ) and have been d e t a i l e d e l s e w h e r e 
( 9 ) . B r i e f l y , samples were e x t r a c t e d by a d s o r p t i o n t o A m b e r l i t e 
XAD-2 a d s o r b e n t r e s i n . The f i n a l t i t e r o f t h e C - t e r m i n a l d i r e c t e d 
a n t i b o d y Toni I I I was 1:120000, crossreactiνity t o r a t - p r o ANF was 
48% and t h e assay s e n s i t i v i t y was 0.5 f m o l a l p h a human ANF/tube. 
The 50% b i n d i n g i n t e r c e p t o f t h e s t a n d a r d c u r v e was 10 f m o l . 
C h r o m a t o g r a p h i c a n a l y s i s o f ANF i m m u n o r e a c t i v i t y . A s c i t i c f l u i d 
e x t r a c t s of 4 p a t i e n t s were s u b j e c t e d t o h i g h p e r f o r m a n c e g e l p e r ­
m e a t i o n c h r o m a t o g r a p h y (HPGPC) and r e v e r s e phase h i g h p e r f o r m a n c e 
c h r o m a t o g r a p h y (RP-HPC). 
High p e r f o r m a n c e g e l p e r m e a t i o n c h r o m a t o g r a p h y (HPGPC): L y o p h i -
l i z e d a s c i t i c f l u i d (10 m l ) was d i s s o l v e d i n 25μ 1 column e l u e n s 
and a p p l i e d t o a S p h e r o g e l TM TSK, 2000 SW column (ΙΟμπι, 7.5mm χ 
300 mm, Beckman I n s t r u m e n t s , San Rarnon, CA, USA), e l u t e d w i t h 
0.09% t r i f 1 u o r o a c e t i c a c i d (TFA) c o n t a i n i n g 0.005M Na 2S0., 0.002M 
NaHpPO, and 30% a c e t o n i t r i l e ( f l o w r a t e : 0.3 m l / m i n ) . C a l i b r a t i o n 
was c a r r i e d o u t w i t h b o v i n e serum a l b u m i n (BSA) ( V ) , v i t a m i n B12 
( V . ) , r a t pro-ANF ( 2 - 1 2 6 ) and a l p h a human ANF ( 9 9 - 1 2 6 ) . Immuno-
r e a c t i v e ANF (IR-ANF) f r a c t i o n s ( 0 . 6 m l ) , d e t e c t e d by RIA, were 
p o o l e d and l y o p h i 1 i zed. 
Reverse phase h i g h p e r f o r m a n c e c h r o m a t o g r a p h y (RP-HPC): An a l i q u o t 
of t h e p o o l e d IR-ANF f r a c t i o n s o f t h e HPGPC r u n was r e d i s s o l v e d i n 
25 μΐ 0 . 1 % TFA and l o a d e d on a HPLC C 18 ODS U l t r a s p h e r e TM column 
(5 μ m 9 2mmx15 0mm, Beckman I n s t r u m e n t s , San Ramon, USA) a c c o r d i n g t o 
( 1 0 ) . E l u t i o n was c a r r i e d o u t w i t h a l i n e a r g r a d i e n t o f a c e t o n i ­
t r i l e ( 1 0 - 8 0 % , 45 m i n ) i n 0.1%TFA ( f l o w r a t e : 0 . 2 m l / m i n ) . C a l i ­
b r a t i o n o f t h e column was p e r f o r m e d w i t h s y n t h e t i c a t r i o p e p t i n I 
and I I I , a l p h a human ANF ( 9 9 - 1 2 6 ) and r a t pro-ANF ( 2 - 1 2 6 ) . 
F r a c t i o n s ( 0 . 4 m l ) were assayed f o r ANF i m m u n o r e a c t i v i t y . 
S t a t i s t i c a l e v a l u a t i o n . D i f f e r e n c e s between a s c i t i c and p l a s m a t i c 
ANF c o n c e n t r a t i o n s were compared by p a i r e d t - t e s t ; t h e Pearson 
c o r r e l a t i o n c o e f f i c i e n t was d e t e r m i n e d by t h e u s u a l l i n e a r l e a s t 
s q u a r e s t e s t . Data a r e p r e s e n t e d as mean and s t a n d a r d e r r o r 
(M + SEM) . 
R e s u l t s 
Radi o i mmunoas s ay 
S e r i a l d i l u t i o n s o f a s c i t e s were p a r a l l e l t o t h e s t a n d a r d c u r v e , 
as shown i n f i g u r e 1 . R e c o v e r i e s o f 7.8 and 15.6 f m o l s y n t h e t i c 
human a l p h a ANF added t o samples o f a s c i t e s and plasma p r i o r t o 
e x t r a c t i o n were 84% and 67% i n a s c i t e s and 75% and 65% i n ρ l a s in a. 
N o n s p e c i f i c b i n d i n g , d e t e r m i n e d i n t h e RIA w i t h o u t a n t i s e r u m was 
l e s s t h a n 5% i n b o t h a s c i t e s and plasma. A s c i t i c ANF c o n c e n ­
t r a t i o n s were 2.4 + 0.5 f m o l / m l , s i g n i f i c a n t l y ( p < 0.001) l o w e r 
t h a n ANF c o n c e n t r a t i o n s i n plasma (15.5 + 2.6 f m o l / m l ) . ANF l e v e l s 
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i n a s c i t e s were s i g n i f i c a n t l y c o r r e l a t e d t o ANF plasma l e v e l s ( r = 
0.56, ρ < 0 . 0 1 ; f i g u r e 2 ) . 
factor of dilution 
10 10C 1000 10000 
A N F ( f m o l / t u b e ) 
FIG. 1 
A s t a n d a r d c u r v e f o r r a ­
dio i m m u n o a s s a y o f a l p h a 
human ANF ( c i r c l e s ) i n 
c o m p a r i s o n t o s e r i a l d i ­
l u t i o n s o f a s c i t i c f l u i d 
( t r i a n g l e s ) . Each p o i n t 
i s t h e mean o f two expe­
r i m e n t s . D i l u t i o n c u r v e s 
p a r a l l e l t h e s t a n d a r d 
c u r v e s . 
HPLC c h a r a c t e r i z a t i o n o f i m m u n o r e a c t i v e ANF 
When p r e - e x t r a c t e d a s c i t i c f l u i d was c h r o m a t o g r a p h e d on HPGPC and 
r e v e r s e phase HPLC, i m m u n o r e a c t i v e ANF was d e t e c t e d as a s i n g l e 
peak cοeιut i ηg w i t h s y n t h e t i c a l p h a human ANF. No s i g n i f i c a n t 
amounts o f h i g h e r m o l e c u l a r w e i g h t A N F - l i k e m a t e r i a l such as p r e ­
c u r s o r pro-ANF was d e t e c t e d , as d e m o n s t r a t e d i n f i g u r e 3. 
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φ ο <0 
f r a c t i o n n u m b e r 
FIG. 3 
HPLC a n a l y s i s o f i m m u n o r e a c t i v e ANF i n a s c i t i c f l u i d 
A: HPGPC: The v o i d (V ) and t o t a l ( V . ) volumes o f t h e column were 
d e t e r m i n e d by BSA and v i t a m i n Β T2, r e s p e c t i v e l y . The e l u t i o n 
p o s i t i o n s o f s y n t h e t i c r a t - p r o - A N F ( 2 - 1 2 6 ) (p-ANF) and a l p h a 
human ANF (ANF) are i n d i c a t e d by a r r o w s . F r a c t i o n s were t e s t e d 
f o r i m m u n o r e a c t i v e ANF by RIA. 
Β: Reverse phase HPLC: Ar r o w s i n d i c a t e t h e e l u t i o n p o s i t i o n s o f 
a t r i o p e p t i n I (AP I ) , a t r i o p e p t i n I I I (AP I I I ) , a l p h a human ANF 
(ANF) and r a t p r o - ANF ( 2 - 1 2 6 ) (p-ANF). I m m u n o r e a c t i v e ANF was 
e v a l u a t e d by RIA. 
D i s c u s s i o n 
T h i s s t u d y d e m o n s t r a t e s t h e p r e s e n c e o f ANF i n a s c i t i c f l u i d o f 
p a t i e n t s w i t h c i r r h o s i s o f t h e l i v e r . E x t r a c t i o n p r o c e d u r e s as 
w e l l as c h a r a c t e r i s t i c s o f our h i g h l y s e n s i t i v e and s p e c i f i c 
r a d i o i m m u n o a s s a y f o r d e t e r m i n a t i o n o f ANF i n plasma have been 
p r e v i o u s l y d e s c r i b e d ( 6 , 9 ) . A p p l i c a t i o n o f t h e e x t r a c t i o n p r o c e ­
d u r e t o a l i q u o t s o f a s c i t i c f l u i d y i e l d e d h i g h r e c o v e r y r a t e s , n o t 
d i f f e r e n t f r o m t h o s e o b t a i n e d i n plasma. V a l i d i t y o f t h e RIA f o r 
ANF measurement i n a s c i t e s was d e m o n s t r a t e d by p a r a l l e l i t y o f 
s e r i a l d i l u t i o n c u r v e s w i t h t h e s t a n d a r d c u r v e and by t h e absence 
o f s i g n i f i c a n t b i n d i n g i n t e r f e r e n c e . 
I n an a t t e m p t t o f u r t h e r c h a r a c t e r i z e ANF i m m u n o r e a c t i v i t y i n 
a s c i t e s , che m o l e c u l a r w e i g h t p a t t e r n was i n v e s t i g a t e d by h i g h 
p e r f o r m a n c e g e l p e r m e a t i o n c h r o m a t o g r a p h y and r e v e r s e phase HPLC. 
Whereas t r a c e amounts o f h i g h e r m o l e c u l a r w e i g h t ANF i n plasma o f 
p a t i e n t s w i t h c i r r h o s i s had been r e p o r t e d ( 9 ) , ANF immunoreac-
t i ν i t y i n a s c i t e s c o e l u t e d w i t h s y n t h e t i c a l p h a human ANF, t h e 
main c i r c u l a t i n g f o r m i n human plasma. However, due t o t h e low 
c o n c e n t r a t i o n s o f ANF i n a s c i t e s and t o a 48% o n l y c r o s s r e a c t i v i t y 
o f our a n t i b o d y t o pro-ANF ( 9 ) , t h e p r e s e n c e o f s m a l l amounts o f 
h i g h e r m o l e c u l a r w e i g h t ANF i n a s c i t e s c a n n o t be e x c l u d e d . 
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ANF c o n c e n t r a t i o n s i n a s c i t e s were f o u n d t o be s i g n i f i c a n t l y c o r -
r e l a t e d t o ANF plasma c o n c e n t r a t i o n s . T h i s c o r r e l a t i o n as w e l l as 
c h a r a c t e r i z a t i o n o f a s c i t i c ANF as a l p h a ANF, t h e m a j o r c i r c u -
l a t i n g f o r m o f ANF, may a l l o w t h e s p e c u l a t i o n t h a t a s c i t i c ANF i s 
of plasma o r i g i n . ANF c o n c e n t r a t i o n s i n a s c i t e s were f o u n d t o be 
s i g n i f i c a n t l y l o w e r t h a n i n plasma. Thus, e l e v a t i o n s o f ANF l e v e l s 
i n p lasma o b s e r v e d f o l l o w i n g i n f u s i o n o f a s c i t i c f l u i d ( 3 , 4 , 5 ) 
seem n o t t o be due t o i n c r e a s e d l e v e l s o f ANF i n a s c i t i c f l u i d , 
b u t r a t h e r due t o i n c r e a s e d r e l e a s e o f ANF f o l l o w i n g t h e hemo-
dynamic changes o f i n f u s i o n . 
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